These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10544519)

  • 1. [Synthesis and investigation of protonation properties and lipophilicity of some new quinazolone-3-carboxylic acid derivatives].
    Almási J; Kökösi J; Takácsné NK; Vámos J; Noszál B
    Acta Pharm Hung; 1999 Sep; 69(4):193-201. PubMed ID: 10544519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of potential NMDA and cholecystokinin antagonists. II. Lipophilicity studies on 2-methyl-4-oxo-3H-quinazoline-3-alkyl-carboxylic acid derivatives.
    Almási J; Takács-Novák K; Kökösi J; Vámos J
    Int J Pharm; 1999 Mar; 180(1):13-22. PubMed ID: 10089287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of potential NMDA and cholecystokinin antagonists I. acid-base properties of 2-methyl-4-oxo-3H-quinazoline-3-alkyl-carboxylic acids at the molecular and submolecular levels.
    Almási J; Takács-Novák K; Kökösi J; Noszál B
    Int J Pharm; 1999 Mar; 180(1):1-11. PubMed ID: 10089286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between the structures and physicochemical properties of chemotherapeutic fluoroquinolone agents].
    Szász G; Takácsné NK; Budváriné BZ; Hermecz I; Józan M; Lóre A; Noszál B
    Acta Pharm Hung; 1993 May; 63(3):105-14. PubMed ID: 8362651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physico-chemical profiling of centrally acting molecules for prediction of pharmacokinetic properties].
    Deák K
    Acta Pharm Hung; 2008; 78(3):110-20. PubMed ID: 18986088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis of potential CCK antagonist quinazolone derivatives. II].
    Szabó M; Kökösi A; Kovács A; Orfi L
    Acta Pharm Hung; 1995 Sep; 65(5):175-81. PubMed ID: 7484165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists.
    Colotta V; Catarzi D; Varano F; Calabri FR; Filacchioni G; Costagli C; Galli A
    Bioorg Med Chem Lett; 2004 May; 14(9):2345-9. PubMed ID: 15081038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinazolone-alkyl-carboxylic acid derivatives inhibit transmembrane Ca(2+) ion flux to (+)-(S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid.
    Szárics E; Nyikos L; Barabás P; Kovács I; Skuban N; Temesváriné-Major E; Egyed O; Nagy PI; Kökösi J; Takács-Novák K; Kardos J
    Mol Pharmacol; 2001 Apr; 59(4):920-8. PubMed ID: 11259638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Equilibrium solubility of new potential drugs in water, 1-octanol and cyclohexane].
    Józan M; Takácsné-Novak K; Szász G
    Acta Pharm Hung; 1996 May; 66(3):141-6. PubMed ID: 8975541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [EFfect of quinazolone-alkyl-carboxylic acid derivatives on the transmembrane Ca2+ ion flux mediated by AMPA receptors].
    Szárics E; LaszTóczi B; Nyikos L; Barabás P; Kovács I; Skuban N; Nagy PI; Kökösi J; Takácsné NK; Kardos J
    Acta Pharm Hung; 2002; 72(2):116-22. PubMed ID: 12498038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis of potential CCK antagonist quinazolone derivatives].
    Szabó M; Kökösi J; Orfi L
    Acta Pharm Hung; 1995 Jul; 65(4):133-8. PubMed ID: 7572196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of antagonists for NMDA and AMPA receptors.
    Bolshakov KV; Kim KH; Potapjeva NN; Gmiro VE; Tikhonov DB; Usherwood PN; Mellor IR; Magazanik LG
    Neuropharmacology; 2005 Aug; 49(2):144-55. PubMed ID: 15996563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring.
    Calabri FR; Colotta V; Catarzi D; Varano F; Lenzi O; Filacchioni G; Costagli C; Galli A
    Eur J Med Chem; 2005 Sep; 40(9):897-907. PubMed ID: 15919134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
    Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
    Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete resolution of the microscopic protonation equilibria of N-methyl-D-aspartic acid and related compounds.
    Boros M; Kökösi J; Vámos J; Noszál B
    J Pharm Biomed Anal; 2007 Mar; 43(4):1306-14. PubMed ID: 17161575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: synthesis, biological evaluation, and molecular modeling study.
    Varano F; Catarzi D; Colotta V; Calabri FR; Lenzi O; Filacchioni G; Galli A; Costagli C; Deflorian F; Moro S
    Bioorg Med Chem; 2005 Oct; 13(19):5536-49. PubMed ID: 16087341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thyroid hormones and their precursors. II. Species-specific properties].
    Tóth G; Noszál B
    Acta Pharm Hung; 2014; 84(1):21-37. PubMed ID: 24809164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of protonation macro- and microconstants and octanol/water partition coefficient of the antiinflammatory drug niflumic acid.
    Takács-Novák K; Avdeef A; Box KJ; Podányi B; Szász G
    J Pharm Biomed Anal; 1994 Nov; 12(11):1369-77. PubMed ID: 7849133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionization, lipophilicity and solubility properties of repaglinide.
    Mandić Z; Gabelica V
    J Pharm Biomed Anal; 2006 Jun; 41(3):866-71. PubMed ID: 16520012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-specific lipophilicity of thyroid hormones and their precursors in view of their membrane transport properties.
    Tóth G; Mazák K; Hosztafi S; Kökösi J; Noszál B
    J Pharm Biomed Anal; 2013 Mar; 76():112-8. PubMed ID: 23298914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.